Hepatocellular carcinoma in the U.S.A., etiologic considerations
- 1 February 1979
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 76 (2), 279-287
- https://doi.org/10.1016/0016-5085(79)90334-2
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- ANTIBODY TO HEPATITIS-B CORE ANTIGEN IN PATIENTS WITH PRIMARY HEPATIC CARCINOMAThe Lancet, 1975
- ANTIBODY TO HEPATITIS-B-VIRUS CORE IN MANThe Lancet, 1973
- AUSTRALIA ANTIGEN IN HEPATOCELLULAR CARCINOMAThe Lancet, 1972
- HEPATITIS-ASSOCIATED ANTIGEN AND HEPATOMA IN THE U.S.The Lancet, 1971
- Hepatitis-Associated Antigen and Hepatocellular Carcinoma in TaiwanAnnals of Internal Medicine, 1971
- Australia antigen and primary liver cancerDigestive Diseases and Sciences, 1970
- S.H. ANTIGEN AND CHRONIC LIVER DISEASEThe Lancet, 1970
- HEPATITIS-ASSOCIATED ANTIGEN IN UGANDAN PATIENTS WITH HEPATOCELLULAR CARCINOMAThe Lancet, 1970
- CHRONIC LIVER DISEASE AND PRIMARY LIVER-CELL CANCER WITH HEPATITIS-ASSOCIATED (AUSTRALIA) ANTIGEN IN SERUMThe Lancet, 1970
- VIRAL HEPATITIS, POSTNECROTIC CIRRHOSIS, AND HEPATOCELLULAR CARCINOMAThe Lancet, 1969